Accordingly, RT-qPCR and western blot analysis demonstrated an increase in the expression of proinflammatory cytokines, such as TNF-α, IL-6, and IL-17, in the colon tissues of IBD mice and this was decreased in EVs-treated mice relative to that in untreated IBD mice. The gene discussed is IL17A; the disease is inflammatory bowel disease.